1. Home
  2. AHCO vs ARDX Comparison

AHCO vs ARDX Comparison

Compare AHCO & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.84

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.38

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHCO
ARDX
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
AHCO
ARDX
Price
$10.84
$6.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$13.50
$15.14
AVG Volume (30 Days)
1.4M
4.0M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,244,857,000.00
$2,607,000.00
Revenue This Year
$9.00
$37.75
Revenue Next Year
$6.93
$34.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.33
$3.54
52 Week High
$13.43
$8.40

Technical Indicators

Market Signals
Indicator
AHCO
ARDX
Relative Strength Index (RSI) 33.66 48.48
Support Level $10.80 $5.54
Resistance Level $13.15 $6.44
Average True Range (ATR) 0.54 0.36
MACD -0.28 -0.01
Stochastic Oscillator 2.26 34.47

Price Performance

Historical Comparison
AHCO
ARDX

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: